Injectable Devices for Biological Drugs Market - 2024-2031
The Injectable Devices for Biological Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A Injectable Devices for Biological Drugs Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Type of Product
Both primary and secondary data sources have been used in the global Injectable Devices for Biological Drugs Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
A Injectable Devices for Biological Drugs Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Type of Product
- Glass material*
- Plastic material
- Self-Injection Devices
- Needle-Free Injectors
- Autoinjectors
- Pen Injectors
- Wearable Injectors
- Others
- Skin*
- Intradermal
- Subcutaneous
- Circulatory/Musculoskeletal System
- Intravenous
- Intracardiac
- Intramuscular
- Intraperitoneal
- Organs
- Intravitreal
- Intra-Articular
- Central Nervous System
- Intracerebral
- Intrathecal
- Reusable Pen Injectors*
- Disposable Pen Injectors
- Autoimmune Diseases*
- Hormonal Disorders
- Orphan Diseases
- Aesthetic Treatment
- Other clinical applications
- Pain Management
- Allergies
- Cancer
- Hepatitis C
- HemophiliaOthers
- Hospitals and Clinics*
- Home Care Settings
- Others
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
- Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
- South America (Colombia, Brazil, Argentina, Rest of South America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
- Go-to-market Strategy.
- Neutral perspective on the market performance.
- Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
- Customized regional/country reports as per request and country level analysis.
- Potential & niche segments and regions exhibiting promising growth covered.
- Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Both primary and secondary data sources have been used in the global Injectable Devices for Biological Drugs Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
1. MARKET METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing prevalence of chronic diseases
4.1.1.2. Increase in demand for self-injection devices
4.1.2. Restraints:
4.1.2.1. Needlestick injuries and infections
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis
6. COVID-19 ANALYSIS
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. BY TYPE OF PRODUCT
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
7.1.2. Market Attractiveness Index, By Type of Product
7.2. Glass material*
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2021-2030and Y-o-Y Growth Analysis (%), 2021-2030
7.3. Plastic material
7.3.1. Self-Injection Devices
7.3.2. Needle-Free Injectors
7.3.3. Autoinjectors
7.3.4. Pen Injectors
7.3.5. Wearable Injectors
7.3.6. Others
8. BY SITE OF ADMINISTRATION
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Site of Administration
8.1.2. Market Attractiveness Index, By Site of Administration
8.2. Skin*
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2021-2030
8.2.3. Intradermal
8.2.4. Subcutaneous
8.3. Circulatory/Musculoskeletal System
8.3.1. Intravenous
8.3.2. Intracardiac
8.3.3. Intramuscular
8.3.4. Intraperitoneal
8.4. Organs
8.4.1. Intravitreal
8.4.2. Intra-Articular
8.5. Central Nervous System
8.5.1. Intracerebral
8.5.2. Intrathecal
9. BY USABILITY
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
9.1.2. Market Attractiveness Index, By Usability
9.2. Reusable Pen Injectors*
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2021-2030
9.3. Disposable Pen Injectors
10. BY APPLICATION
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.1.2. Market Attractiveness Index, By Application
10.2. Autoimmune Diseases*
10.2.1. Introduction
10.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2021-2030
10.3. Hormonal Disorders
10.4. Orphan Diseases
10.5. Aesthetic Treatment
10.6. Other clinical applications
10.6.1. Pain Management
10.6.2. Allergies
10.6.3. Cancer
10.6.4. Hepatitis C
10.6.5. HemophiliaOthers
11. BY END USER
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.1.2. Market Attractiveness Index, By End User
11.2. Hospitals and Clinics*
11.2.1. Introduction
11.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2021-2030
11.3. Home Care Settings
11.4. Others
12. BY REGION
12.1. Introduction
12.1.1. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2021-2030, By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Site of Administration
12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.2.8.1. The U.S.
12.2.8.2. Canada
12.2.8.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Site of Administration
12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.3.8.1. Germany
12.3.8.2. The U.K.
12.3.8.3. France
12.3.8.4. Italy
12.3.8.5. Spain
12.3.8.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Site of Administration
12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.4.8.1. Brazil
12.4.8.2. Argentina
12.4.8.3. Rest of South America
12.5. Asia Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Site of Administration
12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.5.8.1. China
12.5.8.2. India
12.5.8.3. Japan
12.5.8.4. Australia
12.5.8.5. Rest of Asia Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Site of Administration
12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13. COMPETITIVE LANDSCAPE
13.1. Key Developments and Strategies
13.2. Company Share Analysis
13.3. Type Benchmarking
14. COMPANY PROFILES
14.1. Baxter International, Inc.*
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Key Highlights
14.1.4. Financial Overview
14.2. Becton, Dickinson and Company
14.3. Gerresheimer AG
14.4. Pfizer, Inc.
14.5. Schott AG
14.6. ELI Lilly and Company
14.7. Sandoz (Novartis AG)
14.8. Terumo Corporation
14.9. Teva Pharmaceutical Industries Ltd.
14.10. Crossject(*LIST NOT EXHAUSTIVE)
15. DATAM INTELLIGENCE
15.1. Appendix
15.2. About Us and Services
15.3. Contact Us
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing prevalence of chronic diseases
4.1.1.2. Increase in demand for self-injection devices
4.1.2. Restraints:
4.1.2.1. Needlestick injuries and infections
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis
6. COVID-19 ANALYSIS
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. BY TYPE OF PRODUCT
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
7.1.2. Market Attractiveness Index, By Type of Product
7.2. Glass material*
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2021-2030and Y-o-Y Growth Analysis (%), 2021-2030
7.3. Plastic material
7.3.1. Self-Injection Devices
7.3.2. Needle-Free Injectors
7.3.3. Autoinjectors
7.3.4. Pen Injectors
7.3.5. Wearable Injectors
7.3.6. Others
8. BY SITE OF ADMINISTRATION
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Site of Administration
8.1.2. Market Attractiveness Index, By Site of Administration
8.2. Skin*
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2021-2030
8.2.3. Intradermal
8.2.4. Subcutaneous
8.3. Circulatory/Musculoskeletal System
8.3.1. Intravenous
8.3.2. Intracardiac
8.3.3. Intramuscular
8.3.4. Intraperitoneal
8.4. Organs
8.4.1. Intravitreal
8.4.2. Intra-Articular
8.5. Central Nervous System
8.5.1. Intracerebral
8.5.2. Intrathecal
9. BY USABILITY
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
9.1.2. Market Attractiveness Index, By Usability
9.2. Reusable Pen Injectors*
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2021-2030
9.3. Disposable Pen Injectors
10. BY APPLICATION
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.1.2. Market Attractiveness Index, By Application
10.2. Autoimmune Diseases*
10.2.1. Introduction
10.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2021-2030
10.3. Hormonal Disorders
10.4. Orphan Diseases
10.5. Aesthetic Treatment
10.6. Other clinical applications
10.6.1. Pain Management
10.6.2. Allergies
10.6.3. Cancer
10.6.4. Hepatitis C
10.6.5. HemophiliaOthers
11. BY END USER
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.1.2. Market Attractiveness Index, By End User
11.2. Hospitals and Clinics*
11.2.1. Introduction
11.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2021-2030
11.3. Home Care Settings
11.4. Others
12. BY REGION
12.1. Introduction
12.1.1. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2021-2030, By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Site of Administration
12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.2.8.1. The U.S.
12.2.8.2. Canada
12.2.8.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Site of Administration
12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.3.8.1. Germany
12.3.8.2. The U.K.
12.3.8.3. France
12.3.8.4. Italy
12.3.8.5. Spain
12.3.8.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Site of Administration
12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.4.8.1. Brazil
12.4.8.2. Argentina
12.4.8.3. Rest of South America
12.5. Asia Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Site of Administration
12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.5.8.1. China
12.5.8.2. India
12.5.8.3. Japan
12.5.8.4. Australia
12.5.8.5. Rest of Asia Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Site of Administration
12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13. COMPETITIVE LANDSCAPE
13.1. Key Developments and Strategies
13.2. Company Share Analysis
13.3. Type Benchmarking
14. COMPANY PROFILES
14.1. Baxter International, Inc.*
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Key Highlights
14.1.4. Financial Overview
14.2. Becton, Dickinson and Company
14.3. Gerresheimer AG
14.4. Pfizer, Inc.
14.5. Schott AG
14.6. ELI Lilly and Company
14.7. Sandoz (Novartis AG)
14.8. Terumo Corporation
14.9. Teva Pharmaceutical Industries Ltd.
14.10. Crossject(*LIST NOT EXHAUSTIVE)
15. DATAM INTELLIGENCE
15.1. Appendix
15.2. About Us and Services
15.3. Contact Us
